| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.8M | +110.3% |
| R&D Expense | $85.4M | +60.2% |
| SG&A Expense | $23.6M | +22.8% |
| Operating Income | -$86.2M | -62.0% |
| Interest Expense | $281K | +10.2% |
| Pre-tax Income | -$88.6M | -67.5% |
| Income Tax | $0 | +100.0% |
| Net Income | -$88.6M | -68.1% |
| EPS (Basic) | -$0.96 |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.5M | +342.3% |
| Current Assets | $97.3M | +11.0% |
| Total Assets | $113.4M | +10.6% |
| Current Liabilities | $25.6M | +28.8% |
| Total Liabilities | $30.1M | +30.6% |
| Stockholders' Equity | $83.3M | +4.8% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$72.6M | -50.9% |
| Capital Expenditures | $306K | -27.3% |
| Investing Cash Flow | -$306K | +27.3% |
| Financing Cash Flow | $77.9M | +54.1% |
| Free Cash Flow | -$72.9M | -50.2% |
| -26.3% |
| EPS (Diluted) | -$0.96 | -26.3% |